BAM
Blueshift Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,710
| Closed | -$376K | – | 1138 |
|
|
2021
Q3 | $376K | Sell |
6,710
-5,671
| -46% | -$318K | 0.02% | 732 |
|
|
2021
Q2 | $751K | Buy |
12,381
+6,176
| +100% | +$375K | 0.04% | 433 |
|
|
2021
Q1 | $435K | Buy |
6,205
+1,477
| +31% | +$104K | 0.04% | 516 |
|
|
2020
Q4 | $283K | Buy |
+4,728
| New | +$283K | 0.03% | 539 |
|
|
2019
Q3 | – | Sell |
-4,914
| Closed | -$214K | – | 902 |
|
|
2019
Q2 | $214K | Buy |
+4,914
| New | +$214K | 0.03% | 638 |
|